Clinical Trials Browser

Not yet recruiting × HER2-positive Colorectal Cancer × regorafenib × Clear all

NCT07384377 2026-02-03

JSKN003 Versus Physician Choiced Treatment in Patients With HER2-positive and Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-Fu, and Irinotecan

Phase 3 Not yet recruiting

Gastrointestinal

HER2-positive Colorectal Cancer